• 11 November 2005
  • News
  • By Narayan Kulkarni

Drugs Going Off Patent

Biogenerics market gaining momentum
Drugs Going Off Patent
 S.No Brand Generic Name Company US Patent
  Name      Expiry
1 Claritin Loratadine Antihistamine Schering-Plough 2002
2 Augmentin Amoxicillin/clavulanate    
    potassium GlaxoSmithKline 2002
3 Intron A Interferon alpha-2b Schering-Plough 2002
4 Axid   Eli Lilly 2002
5 Relafen Nabumetone GlaxoSmithKline 2002
6 Avonex Interferon beta-1a Biogen 2003
7 Humatrope Somatropin Eli Lilly 2003
8 Singulair Montelukast sodium Merck & Co. 2003
9 Flovent Fluticasone propionate GlaxoSmithKline 2003
10 Flonase Fluticasone propionate GlaxoSmithKline 2003
11 Engerix-B   GlaxoSmithKline 2003
12 Nutropin Somatropin Genentech 2003
13 Lovenox Enoxaparin sodium Aventis Pharmaceuticals    2004
14 Diflucan   Pfizer 2004
15 Cipro   Bayer 2004
16 Lupron Leuprolide acetate Tap Pharmaceutical 2004
17 Lamisil Terbinafine hydrochloride Novartis Pharmaceuticals  2004
18 Paraplatin Carboplatin Bristol-Myers Squibb 2004
19 Xenical Orlistat Roche Laboratories 2004
20 Epogen Epoetin alfa Amgen, Johnson  
  or Procrit   & Johnson, and Sankyo 2004
21 Zocor Simvastatin Merck & Co. 2005
22 Prevacid Lansoprazole Tap Pharmaceutical 2005
23 Zoloft Sertraline hydrochloride Pfizer 2005
24 Pravachol Pravastatin Bristol-Myers Squibb 2005
25 Zithromax Azithromycin Pfizer 2005
26 Biaxin Clarithromycin Abbott Laboratories 2005
27 Zofran Ondansetron hydrochloride GlaxoSmithKline 2005

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X